Joseph Edelman, chief executive officer of Perceptive Advisors
(Chris Goodney/Bloomberg)
It may not be one of those hot-shot internet unicorns, but when Kodiak Sciences goes public — possibly next Wednesday — at least one hedge fund firm stands to benefit in a big way. Joseph Edelman’s Perceptive Advisors is an investor in the development-stage biopharmaceutical company,
To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.